ALC Alcon Inc. Ordinary Shares
NYSE · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Feb 24, 2026ALC Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
ALC Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
About Alcon Inc. Ordinary Shares Company overview from Wikipedia
Alcon Inc. (German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies.
## History
Alcon was founded in 1945 as a small pharmacy in Fort Worth, Texas, United States. It was named for its founders, pharmacists Robert Alexander and William Conner who focused on sterile ophthalmic products.
Nestlé of Switzerland purchased Alcon in 1977. Alcon expanded its manufacturing capability with new plants in South America and Europe and drastically increased its investment in research.
In 1979, Alcon acquired Texas Pharmacal Company which became Dermatological Products of Texas (and is now DPT Laboratories).
In 1984, Alcon founded the Technical Excellence Award to promote achievements in R&D excellence and has awarded it to more than 100 recipients. The Alcon product line has expanded from pharmaceuticals to the surgical arena. Today, Alcon has operations in 75 countries and its products are sold in over 180 countries.
Nestlé conducted an initial public offering of 25% of its stake in Alcon in 2002. The stock is traded under the ticker symbol ALC. In July 2008, Novartis purchased approximately 25% of Nestlé's stake in Alcon, with an option to buy Nestlé's remaining shares beginning in 2010. Novartis bought 52% stake from Nestlé for $28.1 Billion. This deal brought the total ownership of Alcon by Novartis to 77%. Beginning January 2010 Novartis formally announced it will be completing the exercise options for finishing purchasing the rest of Alcon and then promptly continue to exercise merger and takeover of Alcon.
On March 29, 2010, Alcon acquired Durezol and Zyclorin from Sirion Therapeutics. Alcon received regulatory approval to acquire the rights of Durezol emulsion in the US and the global rights, excluding Latin America, for Zyclorin from Sirion Therapeutics.
On April 9, 2019, Alcon completed a 100% spin-off from Novartis. The new standalone company is worth up to 28 billion Swiss francs.
In November 2021, Alcon announced it would acquire Ivantis and their glaucoma surgery stent technology for at least $475 million. In August 2022, Alcon agreed to buy Aerie Pharmaceuticals for US$770 million to enhance its ophthalmic pharmaceutical portfolio.
In March 2025, Alcon announced its acquisition of LENSAR, maker of the ALLY Robotic Cataract Laser Treatment System, for $356 million, with the transaction expected to close in the second half of 2025.
In September 2025, Alcon announced the acquisition of LumiThera, Inc., a leader in light-based innovations for ophthalmology.
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | ALC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | 8.85Y avg ≈67.3 | ≈67.3 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | ALC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin | 55.2%5Y avg ≈55.4% | ≈55.4% | · | · | |
| Operating Margin (TTM) | 34.5%5Y avg ≈10.6% | ≈10.6% | · | · | |
| EBITDA Margin | 13.1%5Y avg ≈10.6% | ≈10.6% | · | · | |
| Pretax Margin | 11.2%5Y avg ≈8.6% | ≈8.6% | · | · | |
| Net Profit Margin (TTM) | 30.8%5Y avg ≈7.7% | ≈7.7% | · | · | |
| ROA | 3.2%5Y avg ≈2.5% | ≈2.5% | · | · | |
| ROE | 4.5%5Y avg ≈3.6% | ≈3.6% | · | · | |
| ROIC | 5.2%5Y avg ≈4.3% | ≈4.3% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | ALC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio | 2.15Y avg ≈2.2 | ≈2.2 | · | · | |
| Quick Ratio | 0.55Y avg ≈0.5 | ≈0.5 | · | · | |
| Interest Coverage | 6.75Y avg ≈5.9 | ≈5.9 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | ALC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.35Y avg ≈0.3 | ≈0.3 | · | · | |
| Inventory Turnover | 2.05Y avg ≈1.9 | ≈1.9 | · | · | |
| Revenue / Employee | ≈$416.0K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Dividends Yield, payout ratio, dividend history, 5Y CAGR
| Ex-date | Amount | Currency | Yield |
|---|---|---|---|
| May 5, 2026 | $0.36 | USD | ≈0.48% |
| May 13, 2025 | $0.33 | USD | ≈0.35% |
| May 14, 2024 | $0.26 | USD | ≈0.30% |
| May 10, 2023 | $0.24 | USD | ≈0.29% |
| May 3, 2022 | $0.21 | USD | ≈0.29% |
| May 4, 2021 | $0.11 | USD | ≈0.15% |
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | $0.84 | $0.76 | 10.5% | |
| March 31, 2026 | $0.85 | $0.82 | 3.4% | |
| Dec. 31, 2025 | $0.78 | $0.79 | -1.6% | |
| Sept. 30, 2025 | $0.79 | $0.77 | 2.9% | |
| June 30, 2025 | $0.76 | $0.73 | 4.5% | |
| March 31, 2025 | $0.78 | $0.79 | -1.6% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.40B | $9.91B | $9.46B | $8.72B | $8.29B | $6.83B | $7.51B | $7.15B | $7.18B | $6.50B | $6.29B | $5.60B | |
| Cost of Revenue | $4.59B | $4.33B | $4.14B | $3.91B | $3.58B | $3.83B | $3.72B | $3.96B | $1.68B | $1.61B | $1.47B | $1.40B | |
| Gross Profit | $5.75B | $5.51B | $5.25B | $4.75B | $4.65B | $2.94B | $3.66B | $3.19B | $5.50B | $4.88B | $4.82B | $4.20B | |
| R&D Expense | $990M | $876M | $828M | $702M | $842M | $673M | $656M | $587M | $747M | $665M | $619M | $564M | |
| SG&A Expense | $3.45B | $3.25B | $3.21B | $3.07B | $3.08B | $2.69B | $2.85B | $2.80B | · | · | · | · | |
| Operating Income | $1.36B | $1.41B | $1.04B | $672M | $580M | $-482M | $-187M | $-248M | $2.48B | $2.26B | $2.21B | $1.88B | |
| Interest Expense | $204M | $192M | $189M | $134M | $120M | $124M | $113M | $24M | $9M | $16M | $51M | $50M | |
| Interest Income | $74M | $84M | $45M | $16M | $3M | $6M | $8M | $2M | · | · | · | · | |
| Other Non-op | · | · | · | · | · | · | · | · | $35M | $25M | $-134M | $16M | |
| Pretax Income | $1.16B | $1.26B | $832M | $463M | $418M | $-635M | $-332M | $-300M | $2.53B | $2.31B | $2.08B | $1.93B | |
| Income Tax | $180M | $238M | $-142M | $128M | $42M | $-104M | $324M | $-73M | $317M | $306M | $36M | $343M | |
| Net Income | $980M | $1.02B | $974M | $335M | $376M | $-531M | $-656M | $-227M | $2.21B | $2.01B | $2.05B | $1.59B | |
| EPS (Basic) | $1.99 | $2.06 | $1.98 | $0.68 | $0.77 | $-1.09 | $-1.34 | $-0.46 | $7.34 | $6.72 | $6.86 | $5.32 | |
| EPS (Diluted) | $1.98 | $2.05 | $1.96 | $0.68 | $0.76 | $-1.09 | $-1.34 | $-0.46 | $7.27 | $6.66 | $6.79 | $5.25 | |
| Shares (Basic) | 493,200,000 | 494,400,000 | 493,000,000 | 491,400,000 | 490,000,000 | 489,000,000 | 488,200,000 | 488,200,000 | 300,932,749 | 298,847,072 | 298,504,732 | · | |
| Shares (Diluted) | 496,200,000 | 497,500,000 | 496,500,000 | 494,400,000 | 493,400,000 | 489,000,000 | 488,200,000 | 488,200,000 | 304,104,272 | 301,348,181 | 301,582,676 | 302,162,019,000,000 | |
| EBITDA | $1.36B | $1.41B | $1.04B | $672M | $580M | $-482M | $-187M | · | · | · | · | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.53B | $1.68B | $1.09B | $980M | $1.57B | $1.56B | $822M | $227M | $2.52B | $3.01B | $2.45B | $2.13B | |
| Short-term Investments | · | · | · | · | · | · | · | · | $889M | $479M | $564M | · | |
| Receivables | · | · | · | · | · | · | · | · | $1.48B | $1.35B | $1.17B | · | |
| Inventory | $2.39B | $2.27B | $2.32B | $2.11B | $1.90B | $1.64B | $1.50B | $1.44B | $693M | $626M | $574M | · | |
| Other Current Assets | · | · | · | · | · | · | · | · | $307M | $213M | $243M | · | |
| Current Assets | $6.45B | $6.31B | $5.65B | $5.19B | $5.39B | $4.99B | $4.24B | $3.40B | $6.07B | $5.83B | $5.22B | · | |
| PP&E (Net) | $4.77B | $4.39B | $4.37B | $4.03B | $3.71B | $3.42B | $3.11B | $2.80B | $1.39B | $1.30B | $1.14B | · | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | $2.87B | $2.65B | · | · | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | $1.48B | $1.35B | · | · | |
| Goodwill | $9.26B | $8.95B | $8.93B | $8.93B | $8.90B | $8.90B | $8.90B | $8.90B | $833M | $688M | $645M | · | |
| Intangibles | $9.01B | $8.59B | $9.06B | $9.69B | $8.77B | $9.10B | $10.23B | $10.68B | $953M | $255M | $91M | · | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | $171M | $142M | $92M | · | |
| Total Assets | $31.55B | $30.35B | $29.61B | $29.16B | $28.00B | $27.60B | $27.66B | $27.06B | $10.07B | $8.69B | $7.55B | · | |
| Accounts Payable | · | · | · | · | · | · | · | · | $370M | $321M | $199M | · | |
| Short-term Debt | · | · | · | · | · | · | · | · | $337M | $607M | $1.06B | · | |
| Current Liabilities | $3.05B | $2.28B | $2.40B | $2.74B | $2.47B | $2.26B | $2.30B | $1.89B | $1.79B | $1.98B | $2.19B | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | $65M | $59M | $22M | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | $965M | $691M | $587M | · | |
| Total Liabilities | $9.52B | $8.79B | $8.99B | $9.49B | $8.74B | $8.78B | $8.35B | $4.42B | · | · | · | · | |
| Long-term Debt | · | · | · | · | · | · | · | · | $62M | $56M | $62M | · | |
| Common Stock | · | · | · | · | · | · | · | · | $42M | $42M | $42M | · | |
| Paid-in Capital | · | · | · | · | · | · | · | · | $1.67B | $1.53B | $1.45B | · | |
| Retained Earnings | · | · | · | · | · | · | · | · | $5.71B | $4.53B | $3.70B | · | |
| Treasury Stock | · | · | · | · | · | · | · | · | $263M | $408M | $579M | · | |
| AOCI | · | · | · | · | · | · | · | · | $98M | $203M | $80M | · | |
| Stockholders' Equity | $22.03B | $21.55B | $20.62B | $19.68B | $19.26B | $18.82B | $19.30B | $22.64B | $7.25B | $5.91B | $4.69B | $3.38B | |
| Liabilities + Equity | · | · | · | · | · | · | · | · | $10.07B | $8.69B | $7.55B | · | |
| Shares Outstanding | · | · | · | · | · | · | · | · | 302,390,266 | 299,550,733 | 298,648,353 | 297,662,706 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | · | · | · | · | · | · | · | · | · | $74M | $83M | $84M | |
| Deferred Tax | · | · | · | · | · | · | · | · | $4M | $51M | $-146M | $-26M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | $60M | $24M | $29M | $51M | |
| Operating Cash Flow | $2.27B | $2.08B | $1.39B | $1.22B | $1.34B | $823M | $920M | $1.14B | $2.38B | $2.42B | $2.03B | $1.47B | |
| CapEx | $543M | $473M | $658M | $636M | $700M | $479M | $553M | $524M | $309M | $342M | $302M | $227M | |
| Investing Cash Flow | $-1.34B | $-1.17B | $-1.09B | $-1.86B | $-1.20B | $-572M | $-1.01B | $-1.00B | $-1.71B | $-390M | $-365M | $-227M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | $0 | $0 | $1M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | $33M | $7M | $127M | $1.00B | |
| Dividends Paid | $166M | $130M | $116M | $100M | $54M | $0 | $0 | · | $1.04B | $1.05B | $749M | $613M | |
| Financing Cash Flow | $-1.12B | $-322M | $-211M | $-8M | $-123M | $466M | $659M | $-78M | $-1.15B | $-1.48B | $-1.33B | $-607M | |
| Net Change in Cash | · | · | · | · | · | · | · | · | $-482M | $558M | $315M | $645M | |
| Taxes Paid | · | · | · | · | · | · | · | · | $284M | $262M | $232M | · | |
| Free Cash Flow | $1.73B | $1.60B | $730M | $581M | $645M | $344M | $367M | · | · | · | · | · | |
| Levered FCF | $1.56B | $1.45B | $509M | $484M | $537M | $240M | $144M | · | · | · | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 55.2% | 55.6% | 55.5% | 54.5% | 56.1% | 43.0% | 48.8% | · | · | · | · | · | |
| Operating Margin | 13.1% | 14.3% | 11.0% | 7.7% | 7.0% | -7.0% | -2.5% | · | · | · | · | · | |
| Net Margin | 9.4% | 10.3% | 10.3% | 3.8% | 4.5% | -7.8% | -8.7% | · | · | · | · | · | |
| Pretax Margin | 11.2% | 12.7% | 8.8% | 5.3% | 5.0% | -9.3% | -4.4% | · | · | · | · | · | |
| EBITDA Margin | 13.1% | 14.3% | 11.0% | 7.7% | 7.0% | -7.0% | -2.5% | · | · | · | · | · | |
| ROA | 3.2% | 3.4% | 3.3% | 1.2% | 1.4% | -1.9% | -2.4% | · | · | · | · | · | |
| ROE | 4.5% | 4.8% | 4.8% | 1.7% | 2.0% | -2.8% | -3.1% | · | · | · | · | · | |
| ROIC | 5.2% | 5.3% | 5.9% | 2.5% | 2.7% | -2.1% | -1.9% | · | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 2.8 | 2.3 | 1.9 | 2.2 | 2.2 | 1.8 | · | · | · | · | · | |
| Quick Ratio | 0.5 | 0.7 | 0.4 | 0.4 | 0.6 | 0.7 | 0.4 | · | · | · | · | · | |
| Interest Coverage | 6.7 | 7.4 | 5.5 | 5.0 | 4.8 | -3.9 | -1.7 | · | · | · | · | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.3 | · | · | · | · | · | |
| Inventory Turnover | 2.0 | 1.9 | 1.9 | 2.0 | 2.0 | 2.4 | 2.5 | · | · | · | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $20.96 | $19.92 | $19.04 | $17.63 | $16.80 | $13.97 | $15.38 | · | · | · | · | · | |
| Cash Flow / Share | $4.58 | $4.17 | $2.80 | $2.46 | $2.73 | $1.68 | $1.88 | · | · | · | · | · | |
| EPS (TTM) | $1.98 | $2.05 | $1.96 | $0.68 | $0.76 | $-1.09 | $-1.34 | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $10.40B | $9.91B | $9.46B | $8.72B | $8.29B | $6.83B | $7.51B | · | · | · | · | · | |
| Net Income TTM | $980M | $1.02B | $974M | $335M | $376M | $-531M | $-656M | · | · | · | · | · | |
| P/E | 39.8 | 41.4 | 39.9 | 100.8 | 114.6 | -60.5 | -42.2 | · | · | · | · | · | |
| Earnings Yield | 2.5% | 2.4% | 2.5% | 0.99% | 0.87% | -1.7% | -2.4% | · | · | · | · | · | |
| Payout Ratio | 16.9% | 12.8% | 11.9% | 29.8% | 14.4% | · | · | · | · | · | · | · | |
| Annual Payout | $166M | $130M | $116M | $100M | $54M | $0 | $0 | · | · | · | · | · |
Per Share
| Metric | Trend | Q4 2025 | Q4 2021 | Q4 2011 | Q4 2010 |
|---|---|---|---|---|---|
| EPS (TTM) | $1.98 | $0.76 | $7.28 | $6.67 |
Valuation (TTM)
| Metric | Trend | Q4 2025 | Q4 2021 | Q4 2011 | Q4 2010 |
|---|---|---|---|---|---|
| Revenue TTM | $10.40B | $8.29B | $7.18B | $6.50B | |
| Net Income TTM | $980M | $376M | $2.21B | $2.01B | |
| P/E | 39.8 | 114.6 | · | · | |
| Earnings Yield | 2.5% | 0.87% | · | · | |
| Annual Payout | $166M | $54M | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $10.40B | $9.91B | $9.46B | $8.72B | $8.29B |
| Gross Margin % | 55.2% | 55.6% | 55.5% | 54.5% | 56.1% |
| Operating Margin % | 13.1% | 14.3% | 11.0% | 7.7% | 7.0% |
| Net Income | $980M | $1.02B | $974M | $335M | $376M |
| Diluted EPS | $1.98 | $2.05 | $1.96 | $0.68 | $0.76 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 2.1 | 2.8 | 2.3 | 1.9 | 2.2 |
| Quick Ratio | 0.5 | 0.7 | 0.4 | 0.4 | 0.6 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $1.73B | $1.60B | $730M | $581M | $645M |
Institutional owners (13F) 708 filers · $18.3B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 79 (-18 vs prior Q) | 86 (+17 vs prior Q) | 159 (-34 vs prior Q) | 281 (+28 vs prior Q) | +19.8M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $1,698,441,362 | 21,464,480 | 9.28% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $994,564,314 | 14,749,582 | 5.43% | Shares |
| Bank of New York Mellon Corp | $876,189,320 | 13,057,962 | 4.78% | Shares |
| NORGES BANK | $741,431,995 | 10,976,697 | 4.05% | Shares |
| Invesco Ltd. | $696,520,277 | 10,380,332 | 3.80% | Shares |
| Aristotle Capital Management, LLC | $614,295,592 | 9,154,828 | 3.35% | Shares |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $535,795,507 | 7,915,741 | 2.93% | Shares |
| FMR LLC | $514,221,298 | 7,662,988 | 2.81% | Shares |
| UBS Group AG | $480,188,202 | 7,156,307 | 2.62% | Shares |
| Amundi | $445,380,481 | 6,637,563 | 2.43% | Shares |
| SIH Partners, LLLP | $401,949,130 | 5,990,300 | 2.20% | Put option |
| Select Equity Group, L.P. | $390,260,022 | 5,766,342 | 2.13% | Shares |
| Vontobel Holding Ltd. | $381,222,272 | 5,643,891 | 2.08% | Shares |
| Pictet Asset Management Holding SA | $374,595,529 | 5,534,203 | 2.05% | Shares |
| DEUTSCHE BANK AG\ | $358,758,941 | 5,346,631 | 1.96% | Shares |
| UBS Group AG | $338,047,854 | 5,037,971 | 1.85% | Call option |
| GOLDMAN SACHS GROUP INC | $313,837,596 | 4,677,162 | 1.71% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $290,970,295 | 4,315,146 | 1.59% | Shares |
| Allspring Global Investments Holdings, LLC | $274,046,394 | 4,101,263 | 1.50% | Shares |
| ROYAL BANK OF CANADA | $269,495,000 | 4,016,341 | 1.47% | Shares |
| Legal & General Group Plc | $258,055,793 | 3,812,475 | 1.41% | Shares |
| WGI DM, LLC | $232,375,553 | 3,463,123 | 1.27% | Shares |
| Southpoint Capital Advisors LP | $228,140,000 | 3,400,000 | 1.25% | Shares |
| Troy Asset Management Ltd | $207,564,521 | 3,801,548 | 1.13% | Shares |
| BANK OF AMERICA CORP /DE/ | $165,388,819 | 2,464,811 | 0.90% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $160,738,030 | 2,388,071 | 0.88% | Shares |
| CAISSE DES DEPOTS ET CONSIGNATIONS | $160,694,764 | 2,374,092 | 0.88% | Shares |
| JPMORGAN CHASE & CO | $150,166,761 | 2,221,073 | 0.82% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $149,522,514 | 2,228,302 | 0.82% | Shares |
| VANGUARD ASSET MANAGEMENT, Ltd | $145,859,114 | 2,163,119 | 0.80% | Shares |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $141,279,713 | 2,091,787 | 0.77% | Shares |
| CANADA PENSION PLAN INVESTMENT BOARD | $132,275,538 | 1,958,303 | 0.72% | Shares |
| Focus Partners Wealth | $128,096,242 | 1,907,874 | 0.70% | Shares |
| BARCLAYS PLC | $125,758,821 | 1,874,200 | 0.69% | Shares |
| D. E. Shaw & Co., Inc. | $124,655,897 | 1,857,763 | 0.68% | Shares |
| CIBC Private Wealth Group LLC | $120,584,118 | 1,618,796 | 0.66% | Shares |
| Bank Julius Baer & Co. Ltd, Zurich | $120,549,426 | 1,781,615 | 0.66% | Shares |
| Clearbridge Investments, LLC | $113,074,300 | 1,685,161 | 0.62% | Shares |
| THORNBURG INVESTMENT MANAGEMENT INC | $109,653,266 | 1,632,356 | 0.60% | Shares |
| CITIGROUP INC | $104,476,376 | 1,543,514 | 0.57% | Shares |
| 1832 Asset Management L.P. | $101,140,031 | 1,507,303 | 0.55% | Shares |
| KING LUTHER CAPITAL MANAGEMENT CORP | $99,143,873 | 1,477,554 | 0.54% | Shares |
| Compagnie Lombard Odier SCmA | $92,664,274 | 1,369,005 | 0.51% | Shares |
| Liontrust Investment Partners LLP | $92,504,035 | 1,366,637 | 0.51% | Shares |
| Fiera Capital Corp | $92,410,523 | 1,377,206 | 0.50% | Shares |
| MORGAN STANLEY | $90,174,065 | 1,343,873 | 0.49% | Shares |
| PRIMECAP MANAGEMENT CO/CA/ | $89,972,108 | 1,340,866 | 0.49% | Shares |
| Rudius Management LP | $87,761,029 | 1,307,914 | 0.48% | Shares |
| Banque Cantonale Vaudoise | $78,402,000 | 1,158,270 | 0.43% | Shares |
| Allianz Asset Management GmbH | $75,013,727 | 1,108,247 | 0.41% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Novartis AG ×8 filings | March 25, 2011 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 35 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| EQTY · Valued Advisers Trust | 2.98% | 616,566 NS | July 31, 2026 | N-PORT |
| EWL · iShares, Inc. | 1.98% | 685,049 SH | Sept. 11, 2026 | Daily |
| IXJ · iShares Trust | 0.42% | 262,111 SH | Sept. 11, 2026 | Daily |
| ESGD · iShares Trust | 0.33% | 602,662 SH | Sept. 11, 2026 | Daily |
| DMXF · iShares Trust | 0.30% | 42,350 SH | Sept. 11, 2026 | Daily |
| IEV · iShares Trust | 0.24% | 57,904 SH | Sept. 11, 2026 | Daily |
| IEUR · iShares Trust | 0.21% | 289,698 SH | Sept. 11, 2026 | Daily |
| VGK · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.21% | 1,170,257 SH | Aug. 19, 2026 | Daily |
| EFV · iShares Trust | 0.19% | 900,048 SH | Sept. 11, 2026 | Daily |
| DFIV · Dimensional ETF Trust | 0.16% | 488,152 NS | July 31, 2026 | N-PORT |
| PABD · iShares Trust | 0.16% | 7,623 SH | Sept. 11, 2026 | Daily |
| IMFL · Invesco Exchange-Traded Self-Indexe… | 0.15% | 24,889 SH | Oct. 1, 2026 | Daily |
| EFA · iShares Trust | 0.15% | 1,767,646 SH | Sept. 11, 2026 | Daily |
| INTF · iShares Trust | 0.14% | 80,343 SH | Sept. 11, 2026 | Daily |
| IEFA · iShares Trust | 0.13% | 3,717,633 SH | Sept. 11, 2026 | Daily |
| EFG · iShares Trust | 0.11% | 274,128 SH | Sept. 11, 2026 | Daily |
| IDEV · iShares Trust | 0.11% | 532,238 SH | Sept. 11, 2026 | Daily |
| DFAI · Dimensional ETF Trust | 0.10% | 262,271 NS | July 31, 2026 | N-PORT |
| DFIC · Dimensional ETF Trust | 0.10% | 221,136 NS | July 31, 2026 | N-PORT |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0.10% | 4,758,876 SH | Aug. 19, 2026 | Daily |
| VSGX · VANGUARD WORLD FUND | 0.10% | 98,214 SH | Aug. 19, 2026 | Daily |
| PXF · Invesco Exchange-Traded Fund Trust … | 0.10% | 44,917 SH | Oct. 1, 2026 | Daily |
| ACWX · iShares Trust | 0.09% | 161,852 SH | Sept. 11, 2026 | Daily |
| VEU · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.08% | 1,139,139 SH | Aug. 19, 2026 | Daily |
| IXUS · iShares Trust | 0.08% | 679,394 SH | Sept. 11, 2026 | Daily |
| VXUS · VANGUARD STAR FUNDS | 0.07% | 7,162,408 SH | Aug. 19, 2026 | Daily |
| DXIV · Dimensional ETF Trust | 0.07% | 2,004 NS | July 31, 2026 | N-PORT |
| DFAX · Dimensional ETF Trust | 0.07% | 116,867 NS | July 31, 2026 | N-PORT |
| DFSI · Dimensional ETF Trust | 0.06% | 10,784 NS | July 31, 2026 | N-PORT |
| EFAV · iShares Trust | 0.05% | 38,852 SH | Sept. 11, 2026 | Daily |
| TOK · iShares Trust | 0.04% | 1,354 SH | Sept. 11, 2026 | Daily |
| URTH · iShares, Inc. | 0.04% | 44,091 SH | Sept. 11, 2026 | Daily |
| ACWI · iShares Trust | 0.03% | 158,434 SH | Sept. 11, 2026 | Daily |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.03% | 419,654 SH | Aug. 19, 2026 | Daily |
| CRBN · iShares Trust | 0.02% | 3,453 SH | Sept. 11, 2026 | Daily |
ALC Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
12-Month Price Target
15 analysts · 2026-09-30Mean target $84.45 +32.4%
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.